Filtered By:
Management: Food and Drug Administration (FDA)

This page shows you your search results in order of relevance. This is page number 3.

Order by Relevance | Date

Total 1110 results found since Jan 2013.

FDA Approves First Drug To Treat Peanut Allergies In Children
(CNN) — The US Food and Drug Administration approved the first drug to treat peanut allergies in children on Friday, following an advisory committee vote of approval in September. The drug, Palforzia, can be used for children between 4 and 17 years old. It’s designed to minimize the incidence and severity of a child’s allergic reaction to peanuts, as even a small amount of exposure can be harmful to children with the allergy. Children are left attempting to avoid exposure to peanuts to avoid reactions. Though that will continue to be necessary with Palforzia, the risk of a reaction will be lessened, says ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 3, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Peanut Allergy Source Type: news

Reply
We appreciate the interest and comments by Turner et  al1 on our brief report “Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy.”2 The impetus for revising the original Consortium for Food Allergy Research (CoFAR) Grading Scale was driven by a request by the US Food and Drug Administration to update our previous sc ale, which was based largely on investigator discretion, with a more nuanced version specific for food allergy and more objective criteria.
Source: Journal of Allergy and Clinical Immunology - August 29, 2022 Category: Allergy & Immunology Authors: R. Sharon Chinthrajah, Alkis Togias, Robert A. Wood, OUtMATCH Study Team Tags: Correspondence Source Type: research

LEAPing into the void
The prevalence of immunoglobulin E –mediated food allergy has reached epidemic levels in much of the world, placing a substantial burden on affected patients, their families, and health systems.1 As of November 2022, there remains only 1 therapeutic option approved by the Food and Drug Administration for the treatment of food aller gy in the United States and it is only indicated for the treatment of pediatric peanut allergy. Meanwhile, no food allergy treatments are currently approved by the Therapeutic Goods Association, the governing body in Australia, where the study by Vale et al,2 to which this editorial refers, was carr ied out.
Source: Annals of Allergy, Asthma and Immunology - March 1, 2023 Category: Allergy & Immunology Authors: Christopher Warren, Sai R. Nimmagadda Tags: Editorial Source Type: research

Liquid drops could replace allergy shots
In Europe, some allergy sufferers are given allergy drops to treat their symptoms. The Food and Drug Administration has yet not approved these drops for use in the United States, but new evidence published this week could pave the way for American pharmaceutical companies.
Source: WDSU.com - Health - March 28, 2013 Category: Consumer Health News Source Type: news

Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet
Dateline City:  WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Biologics License Application (BLA) for its investigational ragweed pollen (Ambrosia artemisiifolia) sublingual allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration (FDA). On March 27, Merck announced that the FDA had also accepted the BLA for its investigational Timothy grass pollen (Phleum pratense) sublingual allergy immunotherapy tablet...
Source: Merck.com - Corporate News - May 8, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Research and Development News Corporate News Latest News Source Type: news

Butterfly Bakery Issues Allergy Alert of Undeclared Walnuts
June 12, 2013 - St. Augustine, FL (PRWEB) - Butterfly Bakery issues allergy alert on undeclared Walnuts in 14.5 ounce Butterfly Bakery Whole Grain Harvest Berry Muffins, UPC 6 43482 60014 8. People who have an allergy or severe sensitivity to Walnuts (a type of tree nut) run the risk of serious or lifethreatening allergic reaction if they consume these products. This product has not been produced since November 26, 2012.
Source: Food and Drug Administration - June 13, 2013 Category: Food Science Source Type: news

Allergist-Reported Trends in the Practice of Food Allergen Oral Immunotherapy
Publication date: January–February 2015 Source:The Journal of Allergy and Clinical Immunology: In Practice, Volume 3, Issue 1 Author(s): Matthew J. Greenhawt , Brian P. Vickery Food allergen oral immunotherapy (OIT) is an experimental, immune-modifying therapy that may induce clinical desensitization in some patients. OIT is still in early phase clinical research, but some providers may offer OIT as a clinical service. To understand the current practices of allergists who perform OIT, an online survey was sent by e-mail to members of the American Academy of Allergy Asthma & Immunology. Among 442 respondents, 61...
Source: The Journal of Allergy and Clinical Immunology: In Practice - January 7, 2015 Category: Allergy & Immunology Source Type: research

Herr Foods Inc. Announces Voluntary Recall of Waffle Works Brand of 4 oz. Double Chocolate Waffle Sandwiches due to Undeclared Milk: Allergy Concern for Those With Milk Allergy
Herr Foods Inc. has initiated a voluntary recall of Waffle Works Brand 4 oz. packages of Double Chocolate Waffle Sandwiches due to an undeclared milk allergen. People who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume these products.
Source: Food and Drug Administration - June 7, 2016 Category: Food Science Source Type: news

Allergy Alert Issued by Whole Foods Market store in Dedham, Massachusetts for In-Store Produced Yogurt and Granola Parfaits due to Undeclared Almonds
The Whole Foods Market store in Dedham, Massachusetts is issuing an allergy alert on single-serve organic vanilla yogurt parfait cups with strawberries and granola, because the granola contained almonds, which were not declared on the label. People who have an allergy or severe sensitivity to almonds run the risk of serious or life-threatening allergic reaction if they consume these products.
Source: Food and Drug Administration - April 10, 2017 Category: Food Science Source Type: news

Schnucks Bakery Issues Allergy Alert on Undeclared Pecans in German Chocolate Cake Labeled as “Schnucks Bakery Deluxe Petite Cake Chocolate Iced Yellow”
Schnucks Bakery, a St. Louis, Mo. establishment, is issuing an allergy alert on 13 German Chocolate Cakes labeled as “Schnucks Bakery Deluxe Petite Cake Chocolate Iced Yellow” that contain pecans that are not listed on the ingredient label. Those with an allergy or severe sensitivity to pecans run the risk of a serious or life-threatening allergic reaction if they consume this product.
Source: Food and Drug Administration - August 9, 2017 Category: Food Science Source Type: news

Guiding Principles for the Recognition, Diagnosis, and Management of Infants with Anaphylaxis: An Expert Panel Consensus
Publication date: Available online 5 February 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Matthew Greenhawt, Ruchi S. Gupta, J. Allen Meadows, Michael Pistiner, Jonathan M. Spergel, Carlos A. Camargo, F. Estelle R. Simons, Philip L. LiebermanInfant anaphylaxis is an emerging risk, with food allergy the most common cause. Although the presentation of anaphylaxis involves the same systems as in older children and adults, there are real-world challenges to identifying symptoms of an allergic emergency in nonverbal children, as well as implementing optimal treatment. Recognition of anaphyl...
Source: The Journal of Allergy and Clinical Immunology: In Practice - February 5, 2019 Category: Allergy & Immunology Source Type: research

Dupilumab for Systemic Allergy Syndrome With Dermatitis.
Abstract Allergic contact dermatitis (ACD) has been traditionally identified as TH1-mediated delayed-type hypersensitivity reactions. There is currently no Food and Drug Administration-approved systemic therapy indicated for ACD. Among patients with ACD, there is a subgroup that experience not only concomitant atopic dermatitis and ACD but also systemic allergic dermatitis driven by allergens encountered through dietary consumption. Basic science and clinical studies have supported the notion that ACD involves a complex interaction between both TH1 and TH2 axes of the secondary immune system on an allergen-by-alle...
Source: Dermatitis - February 28, 2019 Category: Dermatology Authors: Jacob SE, Sung CT, Machler BC Tags: Dermatitis Source Type: research

Unilever Issues Allergy Alert on Undeclared Tree Nut in Limited Quantities of Ben & Jerry ’s Coconut Seven Layer Bar Bulk and Chunky Monkey Pint
Unilever is voluntarily recalling a limited quantity of Ben& Jerry ’s Coconut Seven Layer Bar bulk and Ben& Jerry ’s Chunky Monkey pints, which may inadvertently contain tree nuts including almonds, Brazil nuts, and hazelnuts that are not declared in the ingredient list or allergy information list. Both affected products include a “Contains Walnuts” and a “May contain other tree nuts” label on the bac k of the pack. Persons who have an allergy or severe sensitivity to these undeclared tree nuts run the risk of a serious or life-threatening allergic reaction if they consume the recalled products.
Source: Food and Drug Administration - April 16, 2019 Category: Food Science Source Type: news

Health Tip: Effects of Allergy Medication
-- Allergy medications often contain an antihistamine. Some antihistamines can make users feel drowsy, unfocused and slow to react, says the U.S. Food and Drug Administration. When taking allergy medication, the FDA suggests: Follow directions,...
Source: Drugs.com - Daily MedNews - June 11, 2019 Category: General Medicine Source Type: news

New Contact Lens Elutes Antihistamine for Ocular Allergy New Contact Lens Elutes Antihistamine for Ocular Allergy
A new contact lens that elutes antihistamine has been approved by the US Food and Drug Administration as a treatment for ocular allergies.FDA Approvals
Source: Medscape Allergy Headlines - March 11, 2022 Category: Allergy & Immunology Tags: Ophthalmology News Alert Source Type: news